Clinical trial
The Hemostatic Potential of TDM-621 on Ascending Aortic Surgery
NCT03917862 is registered in ClinicalTrials.gov with University of Sao Paulo General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Hemostatic Potential of TDM-621 on Ascending Aortic Surgery
- Lead sponsor
- University of Sao Paulo General Hospital
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- December 4, 2018
- Completion date
- December 31, 2020
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ascending aorta abnormality, ascending aorta aneurysm, ascending aortic dissection